Günseli Orhun1, Erdem Tüzün2, Başar Bilgiç3, Perihan Ergin Özcan4, Serra Sencer5, Mehmet Barburoğlu5, Figen Esen4. 1. Department of Anesthesiology and Intensive Care, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. gunseli_orhun@hotmail.com. 2. Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. 3. Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. 4. Department of Anesthesiology and Intensive Care, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. 5. Department of Neuroradiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Abstract
BACKGROUND: Sepsis-induced brain dysfunction (SIBD) is often encountered in sepsis patients and is related to increased morbidity. No specific tests are available for SIBD, and neuroimaging findings are often normal. In this study, our aim was to analyze the diagnostic value of volumetric analysis of the brain structures and to find out its significance as a prognostic measure. METHODS: In this prospective observational study, brain magnetic resonance imaging (MRI) sections of 25 consecutively enrolled SIBD patients (17 with encephalopathy and 8 with coma) and 22 healthy controls underwent volumetric evaluation by an automated segmentation method. RESULTS: Ten SIBD patients had normal MRI, and 15 patients showed brain lesions or atrophy. The most prominent volume reduction was found in cerebral and cerebellar white matter, cerebral cortex, hippocampus, and amygdala, whereas deep gray matter regions and cerebellar cortex were relatively less affected. SIBD patients with normal MRI showed significantly reduced volumes in hippocampus and cerebral white matter. Caudate nuclei, putamen, and thalamus showed lower volume values in non-survivor SIBD patients, and left putamen and right thalamus showed a more pronounced volume reduction in coma patients. CONCLUSIONS: Volumetric analysis of the brain appears to be a sensitive measure of volumetric changes in SIBD. Volume reduction in specific deep gray matter regions might be an indicator of unfavorable outcome.
BACKGROUND: Sepsis-induced brain dysfunction (SIBD) is often encountered in sepsis patients and is related to increased morbidity. No specific tests are available for SIBD, and neuroimaging findings are often normal. In this study, our aim was to analyze the diagnostic value of volumetric analysis of the brain structures and to find out its significance as a prognostic measure. METHODS: In this prospective observational study, brain magnetic resonance imaging (MRI) sections of 25 consecutively enrolled SIBD patients (17 with encephalopathy and 8 with coma) and 22 healthy controls underwent volumetric evaluation by an automated segmentation method. RESULTS: Ten SIBD patients had normal MRI, and 15 patients showed brain lesions or atrophy. The most prominent volume reduction was found in cerebral and cerebellar white matter, cerebral cortex, hippocampus, and amygdala, whereas deep gray matter regions and cerebellar cortex were relatively less affected. SIBD patients with normal MRI showed significantly reduced volumes in hippocampus and cerebral white matter. Caudate nuclei, putamen, and thalamus showed lower volume values in non-survivor SIBD patients, and left putamen and right thalamus showed a more pronounced volume reduction in coma patients. CONCLUSIONS: Volumetric analysis of the brain appears to be a sensitive measure of volumetric changes in SIBD. Volume reduction in specific deep gray matter regions might be an indicator of unfavorable outcome.
Authors: Timothy D Girard; James C Jackson; Pratik P Pandharipande; Brenda T Pun; Jennifer L Thompson; Ayumi K Shintani; Sharon M Gordon; Angelo E Canonico; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Crit Care Med Date: 2010-07 Impact factor: 7.598
Authors: Emanuele Iacobone; Juliette Bailly-Salin; Andrea Polito; Diane Friedman; Robert D Stevens; Tarek Sharshar Journal: Crit Care Med Date: 2009-10 Impact factor: 7.598
Authors: Alexander Semmler; Catherine Nichols Widmann; Thorsten Okulla; Horst Urbach; Markus Kaiser; Guido Widman; Florian Mormann; Julia Weide; Klaus Fliessbach; Andreas Hoeft; Frank Jessen; Christian Putensen; Michael T Heneka Journal: J Neurol Neurosurg Psychiatry Date: 2012-11-07 Impact factor: 10.154
Authors: Ramona O Hopkins; Lindell K Weaver; Dave Collingridge; R Bruce Parkinson; Karen J Chan; James F Orme Journal: Am J Respir Crit Care Med Date: 2004-11-12 Impact factor: 21.405
Authors: Andrea Polito; Frédéric Eischwald; Anne-Laure Maho; Angelo Polito; Eric Azabou; Djillali Annane; Fabrice Chrétien; Robert D Stevens; Robert Carlier; Tarek Sharshar Journal: Crit Care Date: 2013-09-18 Impact factor: 9.097
Authors: Maria C Barbosa-Silva; Maiara N Lima; Denise Battaglini; Chiara Robba; Paolo Pelosi; Patricia R M Rocco; Tatiana Maron-Gutierrez Journal: Crit Care Date: 2021-07-06 Impact factor: 9.097